Table 1 Characteristics of the newly diagnosed T2D patients from CRDS database
|  | Overall (n = 32,501) | 1-year follow-up (n = 9816) | 5-year follow-up (n = 1821) |
|---|---|---|---|
Male | 20,235 (62.3) | 6076 (61.9) | 1093 (60.0) |
Female | 12,266 (37.7) | 3740 (38.1) | 728 (40.0) |
Age, years | 56.61 (13.36) | 59.08 (13.51) | 62.71 (13.15) |
HDL-C, mmol/L | 1.06 (0.34) | 1.13 (0.36) | 1.13 (0.35) |
LDL-C, mmol/L | 2.86 (1.10) | 2.92 (1.16) | 2.91 (1.11) |
TC, mmol/L | 4.82 (1.59) | 4.73 (1.48) | 5.01 (1.61) |
triglycerides, mmol/L | 1.61 [1.13, 2.41] | 1.53 [1.04, 2.33] | 1.59 [1.13, 2.35] |
HbA1c, % | 8.86 (2.81) | 7.57 (2.20) | 8.73 (2.75) |
BMI, Kg/m2 | 24.64 (3.94) | 24.47 (3.91) | 24.43 (4.00) |
SBP, mmHg | 132.50 (20.67) | 133.49 (21.36) | 133.70 (21.14) |
DBP, mmHg | 81.25 (12.96) | 79.98 (13.14) | 80.86 (12.69) |
ALT, IU/L | 23.00 [15.10, 38.00] | 20.80 [14.00, 31.00] | 23.00 [16.00, 36.00] |
AST, IU/L | 21.50 [16.80, 31.00] | 21.00 [17.00, 28.00] | 22.00 [17.00, 30.00] |
AST/ALT ratio | 0.94 [0.71, 1.27] | 1.01 [0 75, 1.41] | 1.06 [0.80, 1.43] |
FIB-4 | 1.21 [0.82, 1.88] | 1.31 [0 90 1 99] | 1.37 [0.94, 2.06] |
eGFR†, ml/min/1.73m2 | 101.88[80.17, 125.83] | 94.94[74.47, 118.88] | 92.97[74.61, 116.84] |
Cr, ÎĽmol/L | 67.00 [55.00, 83.00] | 74.00 [59.00, 95.00] | 79.00 [63.00, 100.00] |
HR, bpm | 82.62 (14.20) | 82.82 (14.38) | 82.47 (14.40) |